Privacy Compliance for Biotech & Pharma
Build privacy governance that supports risk management, partner trust, and repeatable oversight.
Biotech and pharmaceutical organizations occupy a distinctive position in the privacy landscape: the data they generate is simultaneously among the most sensitive personal information recognized in law and among the most commercially valuable intellectual property a company can hold. Genetic sequences, clinical trial outcomes, and health records from research participants carry legal protections that go well beyond standard privacy obligations. The organizations and individuals trying to obtain that data without authorization — criminal actors, and in some cases state-sponsored threat actors — understand its value precisely because it is so difficult to replicate.
Clinical research introduces consent obligations that are both exacting and complex to manage at scale. Trial participants have rights over their data that persist well beyond the trial itself. Research ethics boards set collection and retention parameters that must be reflected in your technical controls, not just your consent forms. And when trials run across multiple sites or international partners, the governance challenge multiplies: each jurisdiction in the network may impose its own requirements on how participant data is handled, transferred, and ultimately disposed of.
The supply chain risk is equally significant. Contract research organizations, analytical labs, and academic partners all access sensitive research data under arrangements that vary in how rigorously accountability is assigned. A breach at a CRO is your breach too — regulators and participants will look to the sponsoring organization as the accountable party. Data processing agreements that clearly define obligations, access controls, and incident notification requirements are essential, not optional.
Privacy Horizon works with biotech and pharmaceutical organizations to build privacy and security programs that account for the full scope of these obligations — from participant data governance through IP protection, third-party risk management, and preparation for ISO 27001 or SOC 2 attestation. We understand the intersection of health privacy legislation, research ethics requirements, and commercial information security, and we build programs that satisfy each audience: regulators, research ethics boards, and the enterprise partners and investors who require formal evidence of your controls.
Why Privacy Compliance matters for Biotech & Pharma
Genomic data, clinical trial records, and participant health information sit at the most protected end of the personal information spectrum under Canadian law, and the organizations trying to steal or misuse that data are among the most sophisticated threat actors in existence. A breach affecting trial participant data triggers regulatory scrutiny, potential civil liability, and the kind of reputational damage that affects your ability to recruit future participants and maintain research partnerships. Beyond the ethical dimension, your IP — the research itself — is a primary target for industrial espionage. Privacy and security governance here is not overhead; it is core risk management.
Biotech and pharmaceutical organizations handle some of the most sensitive categories of personal information — genetic data, clinical trial records, and health outcomes — alongside high-value intellectual property that is a frequent target of nation-state and criminal threat actors. Regulatory scrutiny spans data protection law, clinical research ethics requirements, and Health Canada oversight. Research partnerships and global trial networks introduce complex cross-border data governance obligations.
Relevant frameworks: ISO 27001, ISO 27701, SOC 2 Type II, Health-sector privacy legislation (PHIPA-type, provincial), PIPEDA / provincial private-sector privacy laws
Our approach for Biotech & Pharma
We start with a structured review of your research data governance: what participant information you collect, under what consent and ethics board parameters, and how it flows through your research and partner network. The Minimum Viable Privacy baseline addresses your highest-risk gaps — data processing agreements with CROs and partners, access controls on research data repositories, and incident response procedures calibrated to health data obligations. From that foundation, we build toward ISO 27001 and ISO 27701 certification, which increasingly matters for partnerships with health authorities, government research funders, and international collaborators.
What Privacy Compliance includes
We help you establish a credible privacy baseline quickly, then deepen controls where risk is highest — built to satisfy regulators, partners, and enterprise buyers.
Minimum Viable Privacy (MVP)
A credible compliance baseline, fast — then deepen where risk is highest.
Policy & Governance
The policies, roles, and oversight that make compliance repeatable.
ISO 27001 & SOC 2 Preparation
Readiness for the certifications partners and customers expect.
Ongoing Compliance Monitoring
Keep pace with changing obligations and evidence requirements.
Other services for Biotech & Pharma
What's Protecting Your Business from the Next Threat?
Don't wait for a breach to expose your vulnerabilities. Let Privacy Horizon secure your data, ensure compliance, and build lasting trust.